These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21909634)

  • 1. Effects of modafinil on cognitive functions in first episode psychosis.
    Scoriels L; Barnett JH; Soma PK; Sahakian BJ; Jones PB
    Psychopharmacology (Berl); 2012 Mar; 220(2):249-58. PubMed ID: 21909634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of modafinil on emotional processing in first episode psychosis.
    Scoriels L; Barnett JH; Murray GK; Cherukuru S; Fielding M; Cheng F; Lennox BR; Sahakian BJ; Jones PB
    Biol Psychiatry; 2011 Mar; 69(5):457-64. PubMed ID: 21109234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.
    Saavedra-Velez C; Yusim A; Anbarasan D; Lindenmayer JP
    J Clin Psychiatry; 2009 Jan; 70(1):104-12. PubMed ID: 19026265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.
    Sevy S; Rosenthal MH; Alvir J; Meyer S; Visweswaraiah H; Gunduz-Bruce H; Schooler NR
    J Clin Psychiatry; 2005 Jul; 66(7):839-43. PubMed ID: 16013898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.
    Freudenreich O; Henderson DC; Macklin EA; Evins AE; Fan X; Cather C; Walsh JP; Goff DC
    J Clin Psychiatry; 2009 Dec; 70(12):1674-80. PubMed ID: 19689921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.
    Turner DC; Clark L; Pomarol-Clotet E; McKenna P; Robbins TW; Sahakian BJ
    Neuropsychopharmacology; 2004 Jul; 29(7):1363-73. PubMed ID: 15085092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.
    Turner DC; Clark L; Dowson J; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2004 May; 55(10):1031-40. PubMed ID: 15121488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of modafinil on cognitive functions in alcohol dependent patients: a randomized, placebo-controlled trial.
    Joos L; Goudriaan AE; Schmaal L; van den Brink W; Sabbe BG; Dom G
    J Psychopharmacol; 2013 Nov; 27(11):998-1006. PubMed ID: 24045883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of modafinil on mood and cognition in Huntington's disease.
    Blackwell AD; Paterson NS; Barker RA; Robbins TW; Sahakian BJ
    Psychopharmacology (Berl); 2008 Jul; 199(1):29-36. PubMed ID: 18516718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil improves rapid shifts of attention.
    Marchant NL; Kamel F; Echlin K; Grice J; Lewis M; Rusted JM
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):487-95. PubMed ID: 19031073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
    Hester R; Lee N; Pennay A; Nielsen S; Ferris J
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):489-97. PubMed ID: 21186923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of modafinil on prefrontal executive function in schizophrenia.
    Hunter MD; Ganesan V; Wilkinson ID; Spence SA
    Am J Psychiatry; 2006 Dec; 163(12):2184-6. PubMed ID: 17151173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study.
    Gill M; Haerich P; Westcott K; Godenick KL; Tucker JA
    Acad Emerg Med; 2006 Feb; 13(2):158-65. PubMed ID: 16436796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia.
    Pierre JM; Peloian JH; Wirshing DA; Wirshing WC; Marder SR
    J Clin Psychiatry; 2007 May; 68(5):705-10. PubMed ID: 17503979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity.
    Zack M; Poulos CX
    J Psychopharmacol; 2009 Aug; 23(6):660-71. PubMed ID: 18583430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial.
    Lees J; Michalopoulou PG; Lewis SW; Preston S; Bamford C; Collier T; Kalpakidou A; Wykes T; Emsley R; Pandina G; Kapur S; Drake RJ
    Psychol Med; 2017 Oct; 47(13):2358-2368. PubMed ID: 28464963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancing effects of modafinil in healthy volunteers.
    Turner DC; Robbins TW; Clark L; Aron AR; Dowson J; Sahakian BJ
    Psychopharmacology (Berl); 2003 Jan; 165(3):260-9. PubMed ID: 12417966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    Kane JM; D'Souza DC; Patkar AA; Youakim JM; Tiller JM; Yang R; Keefe RS
    J Clin Psychiatry; 2010 Nov; 71(11):1475-81. PubMed ID: 20816042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial.
    Bobo WV; Woodward ND; Sim MY; Jayathilake K; Meltzer HY
    Schizophr Res; 2011 Aug; 130(1-3):106-13. PubMed ID: 21641776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study.
    Goetghebeur P; Dias R
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):287-93. PubMed ID: 18392753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.